Previous 10 | Next 10 |
SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announces update...
Gainers: Ocugen OCGN +76%, Cassava Sciences SAVA +65%, Moleculin Biotech MBRX +47%, Artelo Biosciences (ARTL) +28%, Atossa Therapeutics (ATOS) +20%.Losers: Immunovant IMVT -39%, Dynavax Technologies (DVAX) -19%, Retractable Technolog...
After ‘substantially positive results, Atossa Therapeutics ([[ATOS]] +19.8%) has ended an Australian open-label Phase 2 clinical study of oral Endoxifen administered in the “window of opportunity” between diagnosis of breast cancer and surgery.The study involved seven new...
SEATTLE, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announces ...
Will These Biotech Penny Stocks Continue to See Bullish Momentum? In the past twelve months, biotech penny stocks have risen to fame alongside the coronavirus pandemic. While we have seen case numbers vary in severity, investor interest in biotech stocks continues rising. Yes, there...
Are These Biotech Names On Your List Of Penny Stocks Right Now? Are you looking for penny stocks to buy right now? If you are, you’re not alone. These cheap stocks have attracted the masses recently, and for a good reason. The strength of retail trading groups has become a cl...
SEATTLE, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that i...
New Study By Dr. Steven Quay Concludes that SARS-CoV-2 Came from a Laboratory Wuhan Institute of Virology Research in December 2019 Shows Evidence of Adenovirus Vaccine Experiments in Patients with COVID-19 PR Newswire SEATTLE , Jan. 29, 2021 /PRNewswire/ --&...
So far, in 2021, it seems as though this is the year of penny stocks . Many companies have seen their share prices shoot up in the triple or even quadruple digits in the past twelve months. While this is not only due to the pandemic, it does have a huge influence. If anything, Covid has...
Helius Medical Technologies (HSDT) -17%.Avinger (AVGR) -12%.Cango (CANG) -11%.OncoCyte (OCX) -10%.Obalon Therapeutics (OBLN) -10%.Dolphin Entertainment (DLPN) -9%.Surgalign Holdings (SRGA) -8% after pricing equity offering at $1.50.Vertex Energy (VTNR) -7%.Atossa Therapeutics (ATOS)...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...